Navigation Links
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Date:10/1/2008

termezzo(R) 3.5 mg or placebo at home, at the time they awakened in the middle of the night and had difficulty returning to sleep. This Phase 3 clinical trial also met its primary endpoint of significantly reducing the time required for the patient to return to sleep versus placebo. After dosing and returning to sleep, patients in the outpatient study who were randomized to Intermezzo(R) also reported fewer subsequent awakenings and less time awake during the remainder of the night. There was no evidence of next day residual sedative effects after middle of the night use of Intermezzo(R) versus placebo.

Glenn A. Oclassen, President and Chief Executive Officer of Transcept, commented, "The submission of the Intermezzo(R) NDA achieves a key milestone for the Transcept team and advances our efforts to gain FDA approval for Intermezzo(R) as the first sleep aid developed specifically to be used in the middle of the night when patients awaken and have difficulty returning to sleep. This NDA submission is the latest in a series of transformative events for Transcept, which have recently included our execution of a definitive merger agreement with Novacea, Inc. Assuming that this proposed merger closes near the end of 2008, Transcept is expected to begin 2009 with an estimated cash balance of $88 to $92 million, which we believe will enable us to carry out our plan to successfully commercialize Intermezzo(R)."

Middle of the Night Awakenings & Intermezzo(R)

According to a recent independent study, conducted by Dr. Maurice Ohayon of the Stanford Sleep Epidemiology Research Center, middle of the night awakening is the most frequently reported insomnia symptom. This study estimates that 35% of American adults experience a middle of the night awakening at least three times per week (Journal of Psychiatric Research, in press).

All of the most commonly prescribed sleep aids are designed to produce approximately seven to eight hours of sleep, and can be
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
2. Critical Pharmaceuticals Enter Sustained Release hGH Arena
3. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
4. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
5. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
6. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
7. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
8. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
9. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
10. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
11. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... N.J. , March 5, 2015 Soligenix, ... stage biopharmaceutical company committed to developing products that address ... and biodefense, announced today that its President and Chief ... give a corporate presentation at the 27 th ... , on Tuesday, March 10, 2015 at 1:00 ...
(Date:3/5/2015)... March 5, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Annual ROTH Conference, to be held March 8-11, 2015, ... James Sapirstein , Chief Executive Officer, will ... live presentation and will be available to participate in ...
(Date:3/5/2015)... Hitachi Medical Systems Europe ... *    at ECR 2015 - the open ... a benchmark for patient-centric care. The new features of ... optimizing workflow management and costs. OASIS demonstrates the high ... imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and General ...
Breaking Medicine Technology:Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3ContraVir to Present at 27th Annual ROTH Conference 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3
... Repro-Med Systems, Inc., (REPR.PK) announced today that it has ... to begin U.S. marketing of its new Subcutaneous Needle ... Flo™ RMS Subcutaneous Needle Sets.  The needle sets are ...  The needle sets have previously been approved and available ...
... Therapeutics, Inc. ("CTI") (NASDAQ: CTICD and MTA: CTIC) announced ... Stock Market LLC (the "NASDAQ"), indicating that CTI has regained ... , NASDAQ Listing Rule 5550(a)(2)) for continued listing on ... compliance with all applicable listing standards. Therefore, the scheduled ...
Cached Medicine Technology:FDA Approves Marketing of RMS Subcutaneous Needle Sets 2FDA Approves Marketing of RMS Subcutaneous Needle Sets 3Cell Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Rule 2
(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... On March 2, 2015, NBC News posted ... Rise, Plastic Surgeons Say,” that comments on the 2014 ... Plastic Surgery and the American Society of ... doubling of surgical butt augmentations performed in 2014. According ... this increase can be attributed to the social impact ...
(Date:3/5/2015)... March 05, 2015 At the ... Beyond,” leaders in addiction treatment met today in Jackson, ... best clinical practices. Among the numerous respected speakers will ... will address the role that pain medications have had ... evidence-based treatment options. , "It is hard to believe ...
(Date:3/5/2015)... 05, 2015 University of Western ... in 1904, has launched a new center of ... changes. The Northwest Center for Lifestyle and Functional ... community outreach, and conduct research in the areas ... and nutrition. The center will target efforts on ...
(Date:3/5/2015)... 2015 Dr. Jonathan Glashow a board ... has been named by Castle Connolly as ... Dr. Glashow has been selected by Castle Connolly Medical ... top specialty care doctors in the tri-state metropolitan New ... program, which carefully screens and selects doctors through a ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2
... leader in end-to-end bill cycle automation, supplies Integrated ... ... Compensation Payers, CONCORD, Calif., Dec. 17 Paradigm ... and complex,medical management services has entered an agreement with ...
... Diagnostic Health Corporation,(DHC) today announced that it ... home office operations to 22 Inverness Center Parkway ... company created,by HealthSouth,s sale of its diagnostic division ... of DHC,s 1,000 employees work in its network ...
... of dying were 50% higher , MONDAY, Dec. 17 (HealthDay ... risk of death, according to a University of Pennsylvania School ... December issue of the Archives of Dermatology . , ... and joints -- has been linked with a number of ...
... People are more pleased with their teeth than professionals might ... People tend to be much happier with the condition of ... report. , Patients also view eyes and teeth as the ... 50 are most at ease with the appearance of their ...
... troubled by,depression usually experience their dark moods in an ... differs only in,that the oscillations follow a seasonal schedule, ... through the spring. Lack of light,is often blamed for ... SAD,sufferers is still in question, reports the January 2008 ...
... Petitions FDA to Require Clearer Warnings on DTC Device,Ads, ... petition with the FDA requesting it require all advertisements ... valve replacements,cosmetic implants and heart stents -- carry a ... the devices once they are in the,body., Implantable ...
Cached Medicine News:Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 2Health News:Paradigm Selects Jopari to Provide E-Billing Gateway for Customers 3Health News:Diagnostic Health Corporation Announces New Home Office Location 2Health News:Severe Psoriasis Linked to Higher Death Risk 2Health News:Dentists Take Dimmer View of Patients' Smiles 2Health News:Dentists Take Dimmer View of Patients' Smiles 3Health News:Dentists Take Dimmer View of Patients' Smiles 4Health News:Lack of Light and Seasonal Depression - What's the Link? From the Harvard Health Letter 2Health News:Advertisements for Medical Devices, Implants Should Carry Warnings of Dangerous Side Effects, Infections 2
... TANGO is designed for ... services, donor centers and ... testing and antibody screening. ... host of functions including ...
The ScanGel® automatic readings are done with a high resolution color video camera. Images can be stored and printed....
... Since the early 1990s, the "Reversed" shoulder ... surgeons with great success. More recently, an ... States have begun to champion this prosthesis ... with it. This reversed technology is the ...
... SPEX Fluorolog-3, a spectro-fluorometer ... JOBIN YVON), is a new ... tailored combination of various components. ... customers to freely choose components ...
Medicine Products: